Is it possible to become a mother after 40?
Yes, it is possible, and it is becoming more and more common. Many women give birth after 40, both naturally and with the help of reproductive technologies (IVF, donor eggs, etc.).
But:
• Fertility drops sharply after 35, and especially after 40.
• The risk of complications is higher: miscarriage, genetic abnormalities, preeclampsia, cesarean section.
• Careful medical supervision and an individual approach are required.
________________________________________
The main causes of infertility in women after 40:
1. Age-related decrease in ovarian reserve
o The number and quality of eggs decreases sharply.
o Age is the main factor in female infertility.
2. Anovulation / irregular ovulation
o Cycles may be irregular, without the release of an egg.
3. Egg quality
o Increased risk of genetic abnormalities (e.g. Down syndrome).
o Often, eggs are not fertilized or do not develop after fertilization.
4. Diseases:
o Endometriosis,
o Uterine fibroids,
o Adhesions after surgery or infections,
o Decreased ovarian function (POF – premature ovarian failure).
5. Problems with a partner (male factor):
o Men also experience a decrease in sperm quality with age, especially after 45.
________________________________________
Why most IVF programs after 40 fail:
1. Poor egg quality
o Even if the egg is retrieved and fertilized, the embryo is often not viable.
2. Chromosomal abnormalities
o After 40, up to 75% of embryos may have aneuploidy (abnormal number of chromosomes).
o This leads to a stop in development or miscarriage.
3. Decreased endometrial receptivity
o Even a good embryo may not take root due to a poor environment in the uterus.
4. Ovarian response to stimulation
o Often few follicles are formed, despite high doses of hormones.
5. General health
o Thyroid disease, diabetes, excess weight, etc. can interfere with implantation.
________________________________________
Every six months after 40 significantly reduces the chances.
________________________________________
REVOLUTIONARY TECHNOLOGY FOR INFERTILITY TREATMENT USING 3D ORGANOIDS
3D ovarian organoids are one of the most advanced and promising technologies in regenerative medicine and reproductive science. They open up new horizons in the treatment of infertility, especially in women with severe ovarian reserve depletion, POF (premature ovarian failure) or after chemotherapy, after many unsuccessful IVF attempts
________________________________________
What are 3D ovarian organoids?
• These are mini-structures grown in the laboratory from stem cells (or primary ovarian cells), which completely imitate the function of real ovarian tissue at the level of structure, biochemistry, and function.
• They are formed in a three-dimensional environment (for example, in a hydrogel), which allows cells to interact more naturally than in conventional 2D cultures.
________________________________________
The goals of creating ovarian organoids:
1. Modeling folliculogenesis (egg development).
2. Production of hormones – estrogens, progesterone.
3. Growing mature eggs for IVF .
4. Personalized medicine — complex cases of infertility that do not respond to therapy
5. Alternative to donation and recovery after oncotherapy.
________________________________________
How it works (simplified):
1. Take induced pluripotent stem cells (iPSCs) or mesenchymal/follicular cells.
2. Place them in a 3D matrix, where they develop into a structure similar to ovarian tissue.
3. Stimulate differentiation into granulosa cells, theca cells, oocyte-like cells.
4. Obtain an organoid capable of performing hormonal and reproductive functions.
________________________________________
Application in the treatment of infertility:
1. Treatment of women with POF and early menopause
• Possibility to reactivate follicles or create conditions for their development.
• Production of your own hormones without HRT (hormone replacement therapy).
2. Alternative to donor eggs
• Potentially, it will be possible to obtain your own eggs from iPSC and grow them in an organoid.
3. Fertility protection after oncotherapy
• 3D culture for subsequent restoration of reproductive function
Introduction into the body:
• “Bio endocrine implant” that is inserted under the adipose tissue
• Organoids are embedded in a biocompatible matrix (hydrogel, collagen, Dekael matrix)
________________________________________
Conclusion:
3D ovarian organoids are the future of reproductive medicine, with the potential to:
• restore fertility even with complete depletion of the ovarian reserve,
• refuse donation,
• individualize infertility treatment.
Introduction of organelles using exosome-based conductors for ovarian rejuvenation
The essence of the method:
• Exosomes (nanoparticles secreted by stem cells) are used, which:
o are able to penetrate tissues (including the ovaries),
o do not cause an immune reaction,
o serve as a transport system.
• Organelles or their components are placed inside the exosomes:
o for example, mitochondria, RNA, enzymes, membrane proteins.
________________________________________
The purpose of the method is to rejuvenate the ovaries:
• Restore the energy potential of cells (by introducing mitochondria),
• Activate folliculogenesis and improve the quality of the egg environment,
• Reduce oxidative stress and inflammation,
• Increase AMH, improve hormonal levels and ovarian reserve.
________________________________________
Which organelles can be delivered:
Organelle Delivery goal Potential effect on the ovaries
Mitochondria Increase ATP production in oocytes and GC Improve metabolism, egg quality
Endoplasmic reticulum (ER)
Correct protein synthesis and stress response Reduce cellular aging
Lysosomes/peroxisomes Detoxification, ROS reduction Combat oxidative stress
MicroRNA, RNA-containing complexes
Regulation of gene expression Reduce apoptosis, reactivation of follicles
________________________________________
Why exosomes are suitable as “conductors”:
• Small (30–150 nm), easily penetrate tissues.
• Targeting can be customized: exosomes carry molecules on their surface that are “recognized” by ovarian cells.
• Exosomes can be loaded with:
o organelles,
o mitochondrial DNA,
o mRNA, proteins, regulatory molecules.
________________________________________
Mechanism of action of the method:
1. Loading exosomes with the necessary components (for example, mitochondria or their fragments).
2. Introduction into the body:
o most often intraperitoneally or intravenously.
3. Targeted delivery: exosomes are sent to the ovarian tissue.
4. Intracellular fusion: the exosome fuses with the cell, transferring the organelle or genetic material.
5. Rejuvenating effect:
o increase in energy potential,
o restoration of the follicular microenvironment,
o reduction in apoptosis and inflammation.
PROCESS DIAGRAM
________________________________________
1. Source of organelles and exosomes
• Organelles:
o Mitochondria (most often)
o Or fragments: mtDNA, proteins, enzymes
• Exosomes:
o From mesenchymal stem cells (MSCs)
________________________________________
2. Loading organelles into exosomes
• Methods:
o Electroporation
o Ultrasonic treatment
o Combination during exosome biogenesis
• Goal: to place organelles or active molecules inside the exosome
________________________________________
3. Modification of exosomes (targeting)
• Adding “address” molecules to the surface (for example, ligands to ovarian cell receptors)
• So that exosomes reach the ovarian tissue
________________________________________
4. Introduction into the body
• Options:
o Intraperitoneally — into the pelvic area
o IV (intravenously) — at a high level of targeting
________________________________________
5. Delivery and action
• The exosome fuses with ovarian cells:
o granulosa, theca cells, possibly — with an oocyte
• Organelles or molecules get inside
• ⚡ Start working:
o restore metabolism
o reduce apoptosis
o activate “dormant” follicles
o stimulate hormonal activity
________________________________________
6. Result (goal of therapy)
• Increase in AMH, FSH, restoration of the menstrual cycle
• Improvement in the quality of eggs
• Increase in the chance of natural conception or IVF success
• General anti-aging effect for the reproductive system
________________________________________
Conclusion:
The method of introducing organelles using exosomes is a new nanotechnology for ovarian rejuvenation. It can:
• Restore mitochondrial function of eggs,
• Increase ovarian reserve,
• Increase chances of pregnancy without donation.
OUR RESULTS OF TREATMENT FEMALE INFERTILITY:
( contact with us , and we will share our treatment results of female infertility)
Each case is assessed by specialists separately, taking into account the features of the medical history, age, methods of therapy that have been tried and their results, the partner and his medical history. There is no single protocol for all cases, there is the possibility of an individual selection of methods that can help you in your situation.